4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-21-018615
Corporate Executive VP & CFO acquired 1,313 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith David Ross Corporate Executive VP & CFO | 2021-05-28 | Grant or award | +1,313 | 16,175 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Smith David Ross Corporate Executive VP & CFO | 2021-05-28 | Grant or award · Stock Options (Right to Buy) | +4,058 | $337.99 | $1,371,563 | 4,058 | D: show line 2 in the form |
Loading xslF345X03/form4.xml…